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Oleic acid has many beneﬁ cial eﬀ ects on human health. 
One of the main dietary sources of oleic acid is olive oil. 
Non-Mediterranean European countries, including Serbia, 
have low habitual olive oil consumption, but other vegeta-
ble oils also contain diﬀ erent amounts of oleic acid. In in-
fants and young children milk is the most important source 
of fatty acids, including oleic acid. Furthermore, fatty acid 
composition of plasma phospholipids reﬂ ects dietary intake 
and fatty acid metabolism. In patients with serious chronic 
diseases fatty acid status is altered independently on the 
intake. Here we reviewed status of oleic acid in healthy per-
sons as well as in patients with diﬀ erent chronic diseases 
in Serbia.
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Ključne reči: fosfolipidi plazme, oleinska kiselina, ma-
slinovo ulje
ABBREVIATIONS
FA- fatty acid 
IDL- intermediate-density lipoprotein
HDL- high-density lipoproteines 
MUFA- monounsaturated fatty acid 
OA- oleic acid
PUFA- polyunsaturated fatty acid
SFA- saturated fatty acid
VLDL- very-low-density lipoprotein
OLIVE OIL AS A KEY COMPONENT
OF MEDITERRANEAN DIET 
Numerous epidemiological, clinical and experimental 
research have shown that consumption of Mediterranean 
diet rich in olive oil has a profound influence on a num-
ber of health outcomes, including obesity, metabolic syn-
drome, cardiovascular disease and diabetes mellitus (1). 
Intensive olive oil intake is inversely associated with both 
systolic and diastolic blood pressure (2), and with stroke 
incidence in elderly populations (3). A major component 
that is responsible for beneficial properties of olive oil is 
oleic acid (OA). Olive oil contains up to 80% monounsatu-
rated fatty acids (MUFA), mostly in the form of OA, rela-
tively low content of saturated (SFA) and polyunsaturated 
fats (PUFA), but also several antioxidant components, in-
cluding phenolic compounds that could partially account 
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Oleinska kiselina ima ima višestruke pozitivne efekte na život i 
zdravlje ljudi. Jedan od glavnih izvora oleinske kiseline je 
maslinovo ulje. Evropske zemlje, koje ne pripadaju mediteranskoj 
regiji, među kojima je i Srbija, retko koriste maslinovo ulje u 
ishrani, ali i druga biljna ulja sadrže oleinsku kiselinu u različitom 
procentu. Kod odojčadi i dece mlađeg uzrasta, mleko je najvažniji 
izvor masnih kiselina, uključujući i oleinsku. Dijetetski unos 
masnih kiselina i njihov metabolizam u telu, odražava 
masnokiselinski sastav u fosfolipidima plazme. Kod pacijenata sa 
teškim hroničnim oboljenjima, masnokiselinski sastav je 
promenjen nezavisno od unosa. U ovom radu je prikazan status 
oleinske kiseline kod zdravih osoba, kao i kod pacijenata sa 
različitim hroničnim oboljenjima u Srbiji. 
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for the observed healthful effects of the Mediterranean 
diet (4). Non-Mediterranean European countries, includ-
ing Serbia, have low habitual olive oil consumption. How-
ever, olive oil is not the only source of OA, it is also a com-
ponent of other vegetable oils, nuts and animal products 
(5, 6), although its concentration depends on the type of 
food, as well as on the region. 
Besides the favorable effects of oleic acid intake in 
adults, it is also essential in infants and children nutrition. 
OA is a component of tissues and membranes, and a major 
fatty acid (FA) component of brain myelin phospholipid, 
which is mainly formed during the two years after birth (7). 
Since OA is rapidly deposited during myelination, its pro-
portion in brain total lipids increases with progressive cen-
tral nervous system myelination (8). Thus intake of OA is of 
a great importance in post-natal life. In infants and young 
children milk is the most important source of fatty acids, 
including OA. Several epidemiological studies reported 
different content of OA and other FA in human colostrum 
(9), transitional and mature milk (10-12), suggesting that 
FA composition of breast milk is markedly influenced by 
geographic differences in maternal dietary composition. 
The similar situation has been shown in cow’s milk sam-
ples, as various interactions were found among diet type, 
cow type and altitude, indicating that a combination of the-
se factors contributes to the characteristic FA profile of the 
respective milk (13). 
Fatty acids have been traditionally considered as pre-
cursors for the biosynthesis of macromolecules and as a 
source of energy, as well as constituents of cellular mem-
branes. However, emerging evidences from several lines 
suggest that dietary FA serve multiple function in the body, 
and are linked not only to health promotion, but also to 
disease pathogenesis. Therefore, the choice of dietary FA 
could markedly influence overall health in humans. De-
pending on the dietary intake of FA, blood phospholipids’ 
FA composition will change (14). In healthy people, the FA 
profile of the serum/plasma phospholipid is an indirect 
biomarker of the average dietary FA intake during the last 
3 to 6 weeks, while the composition of erythrocyte phosp-
holipids reflects the intake during the preceding months 
(15, 16). Nevertheless, a number of physiological and pat-
hologic conditions can influence the FA status in blood. 
Here we reviewed status of OA in plasma phospholipids 
of healthy people of different ages, in professional athletes 
and in patients with chronic diseases in Serbia. 
OLEIC ACID STATUS IN PLASMA PHOSPHOLIPIDS 
Apparently healthy subjects 
Several papers reported FA status in apparently healthy 
subjects in Serbia (14, 17-22). Their content of OA in 
plasma phospholipids is presented in Table 1. As it can 
be seen in the Table, healthy people have similar level of 
OA in plasma from birth to older ages. Slightly lower level 
of OA was found in young adults, but it can be attributed 
to their specific dietary intake which mostly includes fast 
food with low level of OA.
Elite athletes
The status of OA in plasma phospholipids of elite ath-
letes is displayed in Table 2. In comparison to sedentary 
healthy subjects, athletes mostly have lower levels of OA. 
 Table 1. Th e content oleic acid in plasma phospholipids in apparently healthy subjects in Serbia
Author, year (ref No) Sample size Gender (M/F) Mean age mol% of OA
Arsić et al., 2012 (17) 12 n.a. At birth(34-36 weeks of gestation) 11.91 ± 0.73
Arsić et al., 2012 (20) 14 0/14 23.67±1.56 9.03 ± 1.03
Tepšić et al, 2009 (14) 16 16/0 24.0 ±3.0 11.03 ± 1.50
Tepšić et al, 2013 (19) 19 19/0 24.44 ± 3.40 10.46 ± 1.66
Cvetković et al., 2010 (18) 29 15/14 53(23-71) 11.70±1.79
Ristić et al., 2006 (22) 29 17/12 55 ± 9 11.71 ± 1.24
Popović et al., 2009 (21) 15 12/3 60 (54-68) 11.85 ± 1.69
Table 2. Th e content oleic acid in plasma phospholipids of elite athletes in Serbia
Author, year (ref No) Type of sport Sample size Gender Mean age mol% of OA
Petrovic et al., 2016 (23) Handball 17 F 17.2 ±0.93 7.81±0.49
Petrovic et al., 2016 (23) Handball 15 M 18.5±1.06 8.49±0.97
Tepšić et al, 2009 (14) Basketball 23 M 21 ±4 10.69 ± 1.00
Arsić et al., 2012 (20) Football 19 F 21.19±2.45 10.42±1.21
Arsić et al., 2012 (20) Waterpolo 15 F 21.71±4.5 8.85±1.56
Tepšić et al, 2013 (19) Box 16 M 22.41±3.28 14.06 ± 1.50
Tepšić et al, 2009 (14) Football 24 M 24 ± 5 11.01 ± 0.95
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In particular handball players, both male and female, and 
female water polo players (14, 20, 23). On the contrary, 
boxers had significantly higher levels of OA, but their gen-
eral fatty acid status is altered (19).
Chronic non-communicable diseases
Since FA profiles in plasma phospholipids also depend 
on the metabolism, they are often altered in chronic diseases. 
Table 3 presents the OA proportions in patients with different 
diagnoses. It seems that metabolic disorders, such as hyper-
lipidemia (24) and diabetes mellitus type 2 (25) do not affects 
metabolism of OA and its level remain similar as in the control 
group. Patients with non-Hodgkin lymphoma (18) and patients 
on hemodialysis (22) had higher levels of OA (13-14 mol%). 
Serious liver diseases, such as obstructive jaundice (21), and 
in particular alcoholic liver cirrhosis (26), markedly increased 
level of OA in plasma phospholipid, while in contrast rheuma-
toid arthritis (27) decreased OA in comparison to control sub-
jects. The observed changes are unlikely to be a consequence of 
increased (or in patients with rheumatoid arthritis decreased) 
intake, but rather of altered activity of delta-9 desaturase. The 
reasons for these alterations remain to be clarified.
HEALTH BENEFITS OF OLEIC ACID
Oleic acid is the major component that is responsible 
for health benefits of the Mediterranean diet, rich in veg-
etables, fruits and particularly olive oil (28). It has been 
shown that diets with OA are associated with a decreased 
risk of coronary heart disease, cardio-metabolic risk, obe-
sity, type 2 diabetes and hypertension (29, 30). Observa-
tional studies from Mediterranean cohorts have suggested 
that dietary MUFA, in particular OA, may be protective 
against stroke (3), age-related cognitive decline and Al-
zheimer’s disease (30). In addition, insulin sensitivity is 
relatively impaired by diets that are low in oleic acid, or 
rich in trans MUFA or saturated palmitic acid (31). Ris-
ing evidence exists that saturated palmitic acid causes 
insulin resistance via stimulation of inflammatory signal-
ing and production of cytosolic lipid compounds (diacyl-
glycerol and ceramide). OA acts in an opposite direction, 
suggesting that dietary or pharmacologic intervention that 
facilitate transport of FA into the mitochondria would be 
beneficial (32). Moreover, substitution of dietary saturated 
fat by OA and/or PUFA has been described to reduce the 
cardiovascular risk by reducing blood lipids, mainly cho-
lesterol, LDL-cholesterol and triglycerides (33, 34). Nev-
ertheless, Pedersen et al. reported that in healthy men the 
olive oil diet resulted in higher concentrations of VLDL, 
IDL, and LDL particles (number and lipid content) than 
the rapeseed oil and sunflower oil diets (35). 
Furthermore, the authors did not find any differences 
between proportion of OA in serum phospholipids (as a 
biomarker of dietary intake) of patients with hyperlipid-
emia or T2D and healthy controls (25). The percentage 
of OA in adults in this study varied from 10.3% in young 
females, to 11.9% in older male participants. The results 
from other studies showed a strong ecological correlation 
between olive oil intake and oleic acid in plasma phospho-
lipids (36). For instance, a multicenter European cross-sec-
tional study found that participants from northern coun-
tries had lower intake of olive oil and lower OA in plasma 
phospholipids (9.4-10.5%) than people from Spain, Italy 
and Greece (11.2-12.7%) (36), while another study report-
ed 9.5-9.8% of OA in plasma phospholipids of female and 
male subjects in Australia, respectively (37).
Recent findings suggest potential protective effects 
of OA on the promotion and progression of several hu-
man cancers. Several case-control and cohort studies have 
shown that OA and olive oil are associated with a reduc-
tion in the risk of cancer, mainly breast, colorectal and 
prostate cancer (38). Although underlying mechanism 
requires further investigation, protective action on cancer 
may be mediated through several mechanisms, including 
alterations in the composition and structure of tumor cell 
membranes, effects on eicosanoid biosynthesis or intracel-
lular signaling pathways, beneficial influence on cellular 
oxidative stress and DNA damage, and modulation of the 
immune system or gene expression (38-41). Menendez et 
al. have recently revealed that OA suppressed the overex-
pression of HER2 (erbB-2), a well-characterized oncogene 
playing a key role in the etiology, invasive progression and 
metastasis in several human cancers (41, 42). They have 
found that OA directly affected the expression of a cluster 
of interrelated human cancer genes (i.e., HER2, FASN and 
PEA3). However, studies reported higher level of OA in 
plasma phospholipids of patients with non-Hodgkin lym-
phoma and obstructive jaundice (including patients with 
Table 3. Th e content oleic acid in plasma phospholipids in patients with diﬀ erent diagnoses in Serbia
Author, year (ref No) Diagnosis Sample size Gender (M/F) Mean age mol% of OA
Ristić et al., 2006 (22) hemodyalized 37 21/16 52 ± 10 13.05 ± 2.21
Ristić-Medić et al., 2009 (24) hyperlipidemia 78 25/53 56 (45-65) 11.20±  1.0
Ristić-Medić et al., 2006 (25) Type 2 diabetes 28 n.a. 57 ±7 10.46± 2.31
Cvetković et al., 2010 (18) non-Hodgkin lymphoma 47 26/21 57 (19–74) 13.8±1.4
Popović et al., 2009 (21) obstructive jaundice 13 10/3 59 (54-68) 14.31± 2.19
Ristić-Medić et al., 2013 (26) Alcoholic liver cirrhosis 20 18/2 62 (46-72) 18.83± 4.54
Veselinovic et al., 2017 (27) Rheumatoid arthritis 60 0/60 63.1± 9.6 8.64 ± 1.03
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hepatocellular carcinoma) than in healthy subjects (18, 21), 
although we believe that these results arised from an al-
tered delta-9 desaturase activity, rather than an increased 
intake of oleic acid. Nevertheless, a recent study showed 
significantly lower intake of olive oil in patients with lung 
cancer than in the corresponding healthy control subjects 
(43). Thus an appropriate dietary intervention must be car-
ried out in animal models and human pilot studies to con-
firm the possible anti-cancer effects of OA.
DIETARY INTAKE OF OLEIC ACID
In addition to olive oil, another rich source of OA is rape-
seed oil, with 64% of OA (44), thus we suppose that all health 
benefits related to olive oil consumption that could be attrib-
uted to OA, can also be applied to rapeseed oil consumption. 
With an average concentration of about 8 g/l in whole cow’s 
milk, milk and dairy products substantially contribute to the 
dietary intake of oleic acid in many countries (45). However, 
high consumption of milk and/or dairy products is thought 
to contribute to cardiovascular disease, primarily by increa-
sing saturated fat intake, and for that reason many advisory 
bodies recommend avoiding high-fat dairy foods (46). Se-
veral studies have shown that the percentage of undesirable 
SFA in cow’s milk can be replaced with OA by inclusion of 
different feed components in cow’s nutrition. Komprda et al. 
have recently shown that feed mixture containing rapeseed, 
rapeseed oil and rapeseed cakes significantly decreased the 
content of palmitic acid and increased the content of stearic, 
oleic, linoleic and α-linoleic acid in milk of these cows (47). 
Another study has demonstrated that supplementation of a 
basic diet with oilseed, linseed and sunflowerseed improved 
the milk quality from a nutritional point of view by a large 
reduction in the content of saturated FA and an increase in 
the levels of MUFA and PUFA (48). Thus dietary interven-
tion in cows can contribute to healthier milk composition, 
particularly in terms of its FA content. 
Regarding its role in myelinisation, OA is very important 
in infants’ nutrition. Both human milk and infant formulas 
had significantly higher content of OA than cow’s milk (49). 
Moreover, it is the most abundant FA in breast milk and for-
mulas, and an important source of energy for the infants (7). 
To provide an optimal content of OA regardless on the diet, 
only 25% of OA in breast milk originates from the diet dur-
ing the past 48h, while the remaining 75% originates from 
the body stores, mostly adipose tissue, or it is produced by 
interconversion from other FA (50). Nevertheless, Yuhas et 
al. found different proportions of OA in breast milk from 
nine countries, which varied from 21.8% in Philippines to 
36.5% in China, suggesting a significant impact of the diet 
(12). Although OA is not an essential fatty acid, its content in 
human milk is of a great importance, because it reduces the 
melting point of triacylglycerides, thus providing the liquid-
ity required for the formation, transport and metabolism of 
milk fat globules (51). Higher demands for OA in infancy for 
brain development suggest that an increased dietary intake 
of OA in lactating mothers would enhance nutritional qual-
ity of breast milk.
In conclusion, content of oleic acid in serum phospho-
lipids in Serbian population is lower than in Mediterra-
nean countries, but higher than in Northern Europe and it 
increases during life. Considering beneficial effects of OA, 
its increased dietary intake would lead to improvement of 
overall health in the Serbian population. 
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